Older adults with coronary artery disease (CAD) have impaired vascular and inspiratory muscle function. The overarching goal of this double-blind, randomized, crossover, placebo-controlled pilot trial was to inform the development of a fully powered trial to evaluate the effects of dietary nitrate supplementation in older adults with CAD. We aimed to address the following objectives: (a) assess the feasibility, tolerability, and safety of the study protocol; (b) gather preliminary evidence on the effects of nitrate-rich beetroot juice compared with nitrate-depleted beetroot juice (placebo), and estimate the effect sizes; and (c) determine if a full-scale definitive trial is justified.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
8
Participants will drink nitrate rich beetroot juice (2.4 floz ; Beet It Sport Nitrate 400 concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.
Participants will drink nitrate depleted beetroot juice (2.4 floz ; Beet It placebo concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.
Integrative Cardiovascular Physiology Laboratory, University of Florida
Gainesville, Florida, United States
Change in endothelial function
Endothelial function will be determined using brachial artery flow-mediated dilation via high resolution duplex ultrasonography. Reactive hyperemia will be produced by inflating a forearm cuff to \~250 mmHg for 5 minutes followed by rapid deflation.
Time frame: Baseline up to following 2 weeks of experimental condition
Change in inspiratory muscle function
Inspiratory muscle function including strength, power and endurance will be assessed using the POWERbreathe KH2 device
Time frame: Baseline up to following 2 weeks of experimental condition
Change in microvascular function
Microvascular function will be assessed using the forearm blood flow response to submaximal handgrip exercise. Brachial artery blood flow and diameter will be assessed using ultrasound.
Time frame: Baseline up to following 2 weeks of experimental condition
Change in central arterial stiffness
The SphygmoCor XCEL device will be used to measure carotid to femoral pulse wave velocity.
Time frame: Baseline up to following 2 weeks of experimental condition
Change in central arterial hemodynamics
The SphygmoCor XCEL device will be used to obtain central pulse wave analysis.
Time frame: Baseline up to following 2 weeks of experimental condition
Change in functional capacity
Using the Duke Activity Status Index we will assess participants' ability to perform daily activities.
Time frame: Baseline up to following 2 weeks of experimental condition
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.